Complement and apoptosis

Molecular Immunology

Volumn 38, Issue 2-3, 2001, Pages 207-219

  Fishelson, zvi ^a   Attali, Gitit ^a   Mevorach, Dror ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Apoptosis; Cell death; Clearance; Complement; Necrosis

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE 3; CASPASE 9; COMPLEMENT; COMPLEMENT COMPONENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT RECEPTOR; CYTOCHROME C; CYTOKINE; THY 1 ANTIGEN;

ANTIBODY PRODUCTION; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL DEATH; CELL INTERACTION; CELL PROTECTION; CELL STRUCTURE; CELL TYPE; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; COMPLEMENT SYSTEM; CONFERENCE PAPER; CYTOLYSIS; ENZYME ACTIVATION; HUMAN; INFLAMMATION; NECROSIS; NONHUMAN; OPSONIZATION; PHAGOCYTE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

APOPTOSIS; AUTOIMMUNE DISEASES; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS;

EID: 0034874633     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(01)00055-4     Document Type: Short Survey

References (144)

1. Ligated complement receptors do not activate the arachidonic acid cascade in resident peritoneal macrophages
2. Inflammation and Alzheimer's disease
3. Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death
4. Characterization of phosphatidylserine-dependent beta2-glycoprotein I macrophage interactions. Implications for apoptotic cell clearance by phagocytes
5. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis
6. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures
7. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
8. Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis
9. Caspase-dependent proteolysis of integral and peripheral proteins of nuclear membranes and nuclear pore complex proteins during apoptosis
10. Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDa apoptosome complexes
11. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
12. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2
13. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes
14. Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of 'non-self' particles
15. A common set of engulfment genes mediates removal of both apoptotic and necrotic cell corpses in C. elegans
16. Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis
17. Inhibition of serum complement haemolytic activity by lipid vesicles containing phosphatidylserine
18. Pathogenesis of glomerular damage in glomerulonephritis
19. Complement mediated cell death is associated with DNA fragmentation
20. Terminal complement complexes concomitantly stimulate proliferation and rescue of Schwann cells from apoptosis
21. CR3: A general purpose adhesion-recognition receptor essential for innate immunity
22. Caspase inhibitors
23. Two C. elegans genes control the programmed deaths of specific cells in the pharynx
24. Complement factors and their receptors
25. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus
26. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes
27. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF
28. Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells
29. Contribution of heat shock proteins to cell protection from complement-mediated lysis
30. Requirement for croquemort in phagocytosis of apoptotic cells in Drosophila
31. Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death
32. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an anti-inflammatory innate immune response: Implications for systemic autoimmunity
33. Cutting edge: Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages
34. Negative selection of B lymphocytes: A novel role for innate immunity
35. Apoptotic pathways: Paper wraps stone blunts scissors
36. Homologous complement activation on drug-induced apoptotic cells from a human lung adenocarcinoma cell line
37. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability
38. Mutations affecting programmed cell deaths in the nematode Caenorhabditis elegans
39. The biochemistry of apoptosis
40. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus
41. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats
42. C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis
43. Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: Functional relevance and role in inflammation
44. Complement resistance of tumor cells: Basal and induced mechanisms
45. Decreased expression of 20-kD homologous restriction factor (HRF20, CD59) on T lymphocytes in Epstein-Barr virus (EBV)-induced infectious mononucleosis
46. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
47. Selective lysis of early embryonic cells by the alternative pathway of complement - A possible mechanism for programmed cell death in embryogenesis
48. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited
49. BCL-2 gene family and the regulation of programmed cell death
50. Cytolysis of nucleated cells by complement: Cell death displays multi-hit characteristics
51. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis
52. Antibody-independent activation of C1, the first component of complement, by cardiolipin
53. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles
54. Cell desensitization by sublytic C5b-9 complexes and calcium ionophores depends on activation of protein kinase C
55. Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis
56. Mitochondrial control of cell death
57. Production of proinflammatory cytokines by phorbol myristate acetate- treated THP-1 cells and monocyte-derived macrophages after phagocytosis of apoptotic CTLL-2 cells
58. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators
59. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli
60. Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin
61. Candidate adaptor protein CED-6 promotes the engulfment of apoptotic cells in C. elegans
62. Regulation of interleukin-12 by complement receptor 3 signaling
63. Activation of the alternative pathway of complement by apoptotic Jurkat cells
64. The immune response to apoptotic cells
65. Opsonization of apoptotic cells. Implications for uptake and autoimmunity
66. Complement-dependent clearance of apoptotic cells by human macrophages
67. Systemic exposure to irradiated apoptotic cells induces autoantibody production
68. Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation
69. Nucleosome: A major immunogen for pathogenic autoantibody-inducing T cells of lupus
70. Effect of membrane phospholipids on activation of the alternative complement pathway
71. Regulation of complement activation by C-reactive protein
72. Complement activation by apoptotic endothelial cells following hypoxia/reoxygenation
73. Complement membrane attack on nucleated cells: Resistance, recovery and non-lethal effects
74. Regulation of the complement membrane attack pathway
75. Complement deficiency and disease
76. Mesangial cell necrosis in Thy 1 glomerulonephritis - An ultrastructural study
77. The role of complement anaphylatoxin C5a in neurodegeneration: Implications in Alzheimer's disease
78. Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3
79. The membrane attack complex of complement
80. Apoptotic DNA fragmentation
81. Features of systemic lupus erythematosus in Dnase1-deficient mice
82. The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells
83. Caspase structure, proteolytic substrates, and function during apoptotic cell death
84. In situ nick end-labeling detects necrosis of hippocampal pyramidal cells induced by kainic acid
85. Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity
86. Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement
87. Ultrastructural studies of complement mediated cell death: A biological reaction model to plasma membrane injury
88. Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions
89. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement
90. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus
91. Systemic lupus erythematosus, complement deficiency, and apoptosis
92. Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner
93. Sublytic complement attack protects tumor cells from lytic doses of antibody and complement
94. Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis
95. Nonphlogistic clearance of late apoptotic neutrophils by macrophages: Efficient phagocytosis independent of beta(2) integrins
96. Building better vaccines: How apoptotic cell death can induce inflammation and activate innate and adaptive immunity
97. Complement-dependent acceleration of apoptosis in neutrophils by dialyzer membranes
98. Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/alphaMbeta2-integrin glycoprotein
99. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone
100. Sublytic complement attack induces cell cycle in oligodendrocytes
101. The terminal sequence of complement plays an essential role in antibody-mediated renal cell apoptosis
102. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
103. Corpse clearance defines the meaning of cell death
104. Two CD95 (APO-1/Fas) signaling pathways
105. Complement-mediated killing of mesangial cells in experimental glomerulonephritis: Cell death by a combination of apoptosis and necrosis
106. Cytotoxic action and other metabolic consequences of terminal complement proteins
107. DNA degradation in mammalian cells following complement-mediated cytolysis
108. Serial killers: Ordering caspase activation events in apoptosis
109. Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation
110. An alternative, nonapoptotic form of programmed cell death
111. T-cell apoptosis detected in situ during positive and negative selection in the thymus
112. Molecular characterization of mitochondrial apoptosis-inducing factor
113. Cleavage of lamin A by Mch2 alpha but not CPP32: Multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis
114. Enhancement of macrophage phagocytosis upon iC3b deposition on apoptotic cells
115. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo
116. Activation of the alternative pathway of complement by calcium-loaded erythrocytes resulting from loss of membrane phospholipid asymmetry
117. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions
118. Apoptosis in the pathogenesis and treatment of disease
119. Caspases: A decade of death research
120. Apoptosis precedes necrosis of dystrophin-deficient muscle
121. Complement activation in sickle cell disease: A liposome model
122. Activation of the alternative pathway of human complement by apoptotic human umbilical vein endothelial cells
123. Diminished expression of CD59 on activated CD8 + T cells undergoing apoptosis in systemic lupus erythematosus and Sjogren's syndrome
124. A new apoptotic pathway for the complement factor B-derived fragment Bb
125. Regulation of complement membrane attack complex formation in myocardial infarction
126. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: Role of the terminal complement components and inhibition by anti-C5 therapy
127. Bcl-2 proteins: Regulators of apoptosis or of mitochondrial homeostasis?
128. Cell death in development
129. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes
130. Immunosuppressive effects of apoptotic cells
131. Patterns of Cell Death
132. C1q and systemic lupus erythematosus
133. Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients
134. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis
135. Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes
136. The C. elegans cell corpse engulfment gene ced-7 encodes a protein similar to ABC transporters
137. C. elegans phagocytosis and cell-migration protein CED-5 is similar to human DOCK180
138. Cell death: The significance of apoptosis
139. Dissociation of phagocytosis from stimulation of the oxidative metabolic burst in macrophages
140. Complement dependence of antibody-induced mesangial cell injury in the rat
141. CED-1 is a transmembrane receptor that mediates cell corpse engulfment in C. elegans
142. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9